Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: LoLoLoLita who wrote (6741)	4/9/1998 5:08:00 PM
From: david	Read Replies (1) \| Respond to of 23519

i agree. i think this dog will bled little by little, day by day, to 5, which is the most frustrating situation. i personal will try to sell may 7.5 call tommorrow and will hold my shares to see what happen. the street will not believe anything the management team said till they bring in any solid earnings in. to many troubles around the company. good luck. d.

To: LoLoLoLita who wrote (6741)	4/9/1998 6:42:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Dave, I always thought that after seeing the large block trade of 450,000 shares at 10 1/4 and many large blocks traded over the past few months at 10 1/8 and at 11 1/8 that in the eyes of the institutions that given all the "bad" news combined that vivus stock was currently perceived by the institutions to be worth at least about $10.00-$11.00 per share. Now Vivus has to prove itself over the next 2 Quarters and I think they will. I know that my position will be dead money for a while but I intend to be patient as I believe that things will look better and better for Vivus's ability to make money as time progresses. I disagree with David that the stock price will bleed down much further. IMO all the blood is already out of this turnip. At $10.00/share, Vivus is in a position to be bought out by a larger player. If a buy out does take place, the share price would rapidly increase 50 to 100%. I think that the institutions who bought into the stock under 12 realize this and consider this price price as eventual "money in the bank" if a buyout occurs. On the other hand the buyers below 12 will be rewarded even better if things pan out OK over the next two quarters even if no buy out occurs. I think that the buy back at $14.75 average was very poor timing on management's part but maybe it tells us that Vivus's own insiders feel that $15.00/share is a "fair" price. Hindsight is 20/20 so we really can't point a finger unless we know what criteria was used to decide to buy at that price (I will try to find out). Also, they may have had time restrictions on exactly when the shares could be bought back. In hindsight after Decembers drop, I would have kept my powder dry knowing the new 52 week low (9 11/16) and then I would have defended the price at 10 after the pop. If Vivus was at $20 today no one would be complaining about buying at $15.00/share. All in all, I think the price will stay between 9 3/4 and the mid to high 12's for the next month. Any short term positive news will increase the upward potential. I think the short interest will cover now at current prices as well as bargain hunters slowly accumulating with a longer term outlook. It seems that the shorters now know that anything under 10 is a good point to cover as well as the bargain hunters knowing that anything under 10 is a safe buy. For these reasons I see no reason for any further price decline below current support levels. VLAD